GlassScriptPhysician profile
Michelle E Groves
NPI 1689801144
$2,674.28
in general payments reported to CMS, 2019-2025
32 companies · $910 in 2025
The $910 reported for 2025 was more than what 84% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.23 · 2020: $21.75 · 2021: $140 · 2022: $349 · 2023: $436 · 2024: $780 · 2025: $910.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,126.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $638.82 | 2021-2025 | |
| Abbott Laboratories | $310.14 | 2021-2025 | Freestyle Libre 3, Thoratec Heartmate 3 Lvas Implant Kit, Freestyle Libre 2 |
| Novo Nordisk INC | $200.08 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Glaxosmithkline, LLC. | $186.91 | 2019-2025 | Shingrix, Trelegy Ellipta, Arexvy |
| Pfizer INC. | $128.39 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.40 | 2021-2025 | Jardiance, Tradjenta |
| Lilly USA, LLC | $123.25 | 2023-2025 | Mounjaro, Jardiance, Zepbound |
| Exact Sciences Corporation | $105.12 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Merck Sharp & Dohme LLC | $88.27 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Dexcom, INC. | $82.73 | 2021-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $61.99 | 2024-2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $60.08 | 2024-2025 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $57.08 | 2023-2025 | |
| Esperion Therapeutics, INC. | $50.37 | 2024-2025 | Nexletol |
| Pulmonx Corporation | $43.77 | 2025 | Zephyr Delivery Catheter, Chartis Catheter, Zephyr Endobronchial Valve |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $42.69 | 2025 | Sapien 3 Ultra Resilia |
| Axsome Therapeutics, INC. | $40.89 | 2025 | Auvelity |
| Amgen INC. | $39.38 | 2022 | |
| Xeris Pharmaceuticals, INC. | $36.50 | 2023 | Gvoke Hypopen |
| Daiichi Sankyo INC. | $33.93 | 2024-2025 | Injectafer |
| Almatica Pharma LLC | $28.36 | 2024 | Loreev Xr, Teriparatide |
| Kowa Pharmaceuticals America, INC. | $28.21 | 2025 | Zoryve |
| Amarin Pharma, INC. | $21.75 | 2020 | |
| Inspire Medical Systems, INC. | $20.89 | 2025 | Inspire |
| Corcept Therapeutics | $20.79 | 2025 | Korlym |
| Sanofi Pasteur INC. | $19.26 | 2023 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $16.66 | 2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.55 | 2025 | Xifaxan |
| Janssen Pharmaceuticals, INC | $13.72 | 2021 | |
| Idorsia Pharmaceuticals US INC | $13.53 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $12.49 | 2021 | |
| Dynavax Technologies Corporation | $7.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Groves listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.